EPR Properties (NYSE:EPR) is the leading diversified experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate venues that create value by facilitating out of home leisure and recreation experiences where consumers choose to spend their discretionary time and money. We have total assets of approximately $5.7 billion (after accumulated depreciation of approximately $1.5 billion) across 44 states. We adhere to rigorous underwriting and investing criteria centered on key industry, property and tenant level cash flow standards. We believe our focused approach provides a competitive advantage and the potential for stable and attractive returns.

EPR Properties

An update from Essential Properties Realty ( ($EPRT) ) is now available. On June 15, 2026, Essential Properties, L.P., a subsidiary of Essential Pr...

Essential Properties Realty Completes $400 Million Notes Offering

Truist Financial analyst Michael Lewis maintained a Hold rating on EPR Properties today and set a price target of $61.00. According to TipRanks, Le...

EPR Properties (EPR) Receives a Hold from Truist Financial

In a report released yesterday, Simon Yarmak from Stifel Nicolaus maintained a Buy rating on Essential Properties Realty, with a price target of $3...

Stifel Nicolaus Keeps Their Buy Rating on Essential Properties Realty (EPRT)

Eupraxia Pharmaceuticals ( ($TSE:EPRX) ) has issued an update. Eupraxia Pharmaceuticals Inc. has filed a Form 6-K for May 2026, detailing materials...

Eupraxia Pharmaceuticals Sets June 18, 2026 Virtual AGM and Files May Form 6-K

Eupraxia Pharmaceuticals ( ($TSE:EPRX) ) has shared an update. Eupraxia Pharmaceuticals Inc. reported on May 28, 2026 that it has filed a Form 6-K ...

Eupraxia Pharmaceuticals Confirms Mailing of 2026 Proxy Materials to Shareholders

The latest update is out from Eupraxia Pharmaceuticals ( ($TSE:EPRX) ). On May 28, 2026, Eupraxia Pharmaceuticals said its management team will pre...

Eupraxia Pharmaceuticals to Showcase Pipeline at Jefferies Global Healthcare Conference

In a report released on May 22, Michael Carroll from RBC Capital maintained a Hold rating on EPR Properties, with a price target of $61.00. The com...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EPR	$57.51	-0.23%	1.01M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EPR	$57.51	-0.2%	1.01M
3
4
5
6

EPR

EPR

Recent News for EPR

Get EPR Properties Data in Excel

Get EPR Properties Data in Excel